148 related articles for article (PubMed ID: 10354154)
41. In vitro characteristics of cryopreserved platelet concentrates reconstituted by fresh frozen or lyophilized plasma.
Martinaud C; Sugier HHR; Javaudin O; Burin des Roziers N; Bégué S
Transfus Clin Biol; 2022 May; 29(2):118-123. PubMed ID: 35032661
[TBL] [Abstract][Full Text] [Related]
42. Effects of high platelet concentration in collecting and freezing dry platelets concentrates.
Landi EP; Roveri EG; Ozelo MC; Annichino-Bizzacchi JM; Origa AF; de Carvalho Reis AR; de Souza CA; Marques JF
Transfus Apher Sci; 2004 Jun; 30(3):205-12. PubMed ID: 15172625
[TBL] [Abstract][Full Text] [Related]
43. Cryopreservation of human platelets with dimethyl sulfoxide: changes in biochemistry and cell function.
Böck M; Schleuning M; Heim MU; Mempel W
Transfusion; 1995; 35(11):921-4. PubMed ID: 8604489
[TBL] [Abstract][Full Text] [Related]
44. Clinical experience with transfusion of cryopreserved platelets.
Schiffer CA; Aisner J; Wiernik PH
Br J Haematol; 1976 Nov; 34(3):377-85. PubMed ID: 990179
[TBL] [Abstract][Full Text] [Related]
45. Assessment of a dimethyl sulfoxide-stabilized frozen canine platelet concentrate.
Guillaumin J; Jandrey KE; Norris JW; Tablin F
Am J Vet Res; 2008 Dec; 69(12):1580-6. PubMed ID: 19046004
[TBL] [Abstract][Full Text] [Related]
46. Platelet cryopreservation using a combination of epinephrine and dimethyl sulfoxide as cryoprotectants.
Xiao H; Harvey K; Labarrere CA; Kovacs R
Cryobiology; 2000 Sep; 41(2):97-105. PubMed ID: 11034788
[TBL] [Abstract][Full Text] [Related]
47. Platelet cryopreservation. 1. In vitro aggregation studies.
Shepherd KM; Sage RE; Barber S; O'Brien E
Cryobiology; 1984 Feb; 21(1):39-43. PubMed ID: 6713938
[TBL] [Abstract][Full Text] [Related]
48. Cryopreservation of human platelets isolated by discontinuous-flow centrifugation using the Haemonetics Model 30 Blood Processor.
Vecchione JJ; Chomicz SM; Emerson CP; Valeri CR
Transfusion; 1980; 20(4):393-400. PubMed ID: 7404637
[TBL] [Abstract][Full Text] [Related]
49. Buffy coat-derived platelets cryopreserved using a new method: Results from in vitro studies.
Napolitano M; Mancuso S; Lo Coco L; Arfò PS; Raso S; De Francisci G; Dieli F; Caccamo N; Reina A; Dolce A; Agliastro R; Siragusa S
Transfus Apher Sci; 2018 Aug; 57(4):578-581. PubMed ID: 30100202
[TBL] [Abstract][Full Text] [Related]
50. Autologous platelet transfusion in patients receiving high-dose chemotherapy and circulating progenitor cell transplantation for stage II/III breast cancer.
Pedrazzoli P; Perotti C; Noris P; Da Prada GA; Zibera C; Battaglia M; Gibelli N; Preti P; Pavesi L; Torretta L; Balduini CL; Salvaneschi L; Robustelli della Cuna G
Haematologica; 1998 Aug; 83(8):718-23. PubMed ID: 9793256
[TBL] [Abstract][Full Text] [Related]
51. Downscaling platelet cryopreservation: Are platelets frozen in tubes comparable to standard cryopreserved platelets?
Waters L; Marks DC; Johnson L
Transfusion; 2024 Mar; 64(3):517-525. PubMed ID: 38230448
[TBL] [Abstract][Full Text] [Related]
52. Cryopreservation of buffy-coat-derived platelet concentrates in dimethyl sulfoxide and platelet additive solution.
Johnson LN; Winter KM; Reid S; Hartkopf-Theis T; Marks DC
Cryobiology; 2011 Apr; 62(2):100-6. PubMed ID: 21241687
[TBL] [Abstract][Full Text] [Related]
53. Use of different DMSO concentrations for cryopreservation of autologous peripheral blood stem cell grafts does not have any major impact on levels of leukocyte- and platelet-derived soluble mediators.
Akkök CA; Liseth K; Hervig T; Ryningen A; Bruserud Ø; Ersvaer E
Cytotherapy; 2009; 11(6):749-60. PubMed ID: 19878061
[TBL] [Abstract][Full Text] [Related]
54. Calcium chelation: a novel approach to reduce cryopreservation-induced damage to frozen platelets.
Waters L; Padula MP; Marks DC; Johnson L
Transfusion; 2020 Jul; 60(7):1552-1563. PubMed ID: 32319689
[TBL] [Abstract][Full Text] [Related]
55. In vitro comparison of cryopreserved and liquid platelets: potential clinical implications.
Johnson L; Reade MC; Hyland RA; Tan S; Marks DC
Transfusion; 2015 Apr; 55(4):838-47. PubMed ID: 25371169
[TBL] [Abstract][Full Text] [Related]
56. Identification of platelet subpopulations in cryopreserved platelet components using multi-colour imaging flow cytometry.
Johnson L; Lei P; Waters L; Padula MP; Marks DC
Sci Rep; 2023 Jan; 13(1):1221. PubMed ID: 36681723
[TBL] [Abstract][Full Text] [Related]
57. The influence of CS-3000 plateletapheresis on blood donors and on platelet concentrates.
Kotelba-Witkowska B; Mrowiec ZR; Daszyński J; Skrzeczkowska E; Stachecki B; Kaszkowiak M; Jakuboszczak E
Mater Med Pol; 1990; 22(1):29-32. PubMed ID: 2079857
[TBL] [Abstract][Full Text] [Related]
58. Cryopreserved platelets have decreased adhesive capacity.
Owens M; Cimino C; Donnelly J
Transfusion; 1991 Feb; 31(2):160-3. PubMed ID: 1996484
[TBL] [Abstract][Full Text] [Related]
59. Cryopreserved platelets and their suitability in being re-suspended in additive solution.
McLean C; McMillan L; Petrik J; Fraser AR; Morrison A
Vox Sang; 2020 Nov; 115(8):676-685. PubMed ID: 32966615
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of human platelet lysate and dimethyl sulfoxide as cryoprotectants for the cryopreservation of human adipose-derived stem cells.
Wang C; Xiao R; Cao YL; Yin HY
Biochem Biophys Res Commun; 2017 Sep; 491(1):198-203. PubMed ID: 28712869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
